Impact of Deutetrabenazine on Functional Speech and Gait Dynamics in Huntington Disease
Clinical trial NCT04713982 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04713982
- Sponsor
- Vanderbilt University Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-19
- Primary completion
- 2027-06-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.